Profiling familial breast cancer

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature Medicine

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/86464PMID 11283660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

  2001cited by this paper
• Gene-expression profiles in hereditary breast cancer.

  2001cited by this paper
• Gene-expression profiles in hereditary breast cancer.

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor.

  1999cited by this paper
• The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation

  1998cited by this paper
• ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

  1998cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

  1997cited by this paper
• Tumour biological features of BRCA1-induced breast and ovarian cancer.

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

  1997cited by this paper
• Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.

  1995cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.

  1993cited by this paper
• The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript.

  1993cited by this paper
• Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

  1993cited by this paper

• Determinants of Cervical Cancer in Indian context

  2018cites this paper
• Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1.

  2017cites this paper
• Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics

  2014cites this paper
• Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

  2013cites this paper
• A review of PARP inhibitors: from bench to bedside.

  2011cites this paper
• BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

  2010cites this paper
• BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

  2010cites this paper
• Biomarkers for Basal-like Breast Cancer

  2010cites this paper
• Targeting DNA repair in breast cancer: a clinical and translational update.

  2010cites this paper
• The Swedish Family‐Cancer Database 2009: prospects for histology‐specific and immigrant studies

  2010cites this paper
• Regulation of Estrogen Receptor alpha Ubiquitination and Proteasome-mediated Receptor Degradation

  2008cites this paper
• Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer

  2007cites this paper
• Basal-like breast cancer and the BRCA1 phenotype

  2006cites this paper
• MRI for breast cancer screening.

  2006cites this paper
• Microarrays in veterinary diagnostics

  2004cites this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cites this paper
• The role of hypoxia signalling pathways in tumour biology.

  2004cites this paper
• Role of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast Cancer

  2004cites this paper
• Familial risk of cancer by site and histopathology

  2003cites this paper
• Transcription profiling of estrogen target genes in young and old mouse uterus.

  2003cites this paper
• Gene-expression profiles in hereditary breast cancer.

  2002cites this paper
• The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

  2002cites this paper
• Attributable risks for familial breast cancer by proband status and morphology: A nationwide epidemiologic study from Sweden

  2002cites this paper
• Familial breast carcinoma risks by morphology

  2002cites this paper
• Women's Health LiteratureWatch

  2001cites this paper
• Women's health literaturewatch.

  2001cites this paper
• New complexities for BRCA1 and BRCA2.

  2001cites this paper